HK$4.89
1.11%
Hong Kong, Fri, Sep 18 2026.
ISIN
BMG210A71016
Symbol
512

Grand Pharmaceutical Stock price

HK$4.89
-0.51 9.45% 1M
-2.27 31.68% 6M
-2.97 37.77% YTD
-3.89 44.30% 1Y
+0.85 20.92% 3Y
-1.14 18.85% 5Y
+3.25 197.87% 10Y
+4.81 6,684.72% 20Y
Hong Kong, Closing price Fri, Sep 18 2026
-0.06 1.11%
ISIN
BMG210A71016
Symbol
512
Industry

Is Grand Pharmaceutical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,133 stocks worldwide.

Key metrics

Basic
Market capitalization
HK$17.5b
Enterprise Value
HK$21.4b
Net debt
HK$3.8b
Cash
HK$1.2b
Shares outstanding
3.5b
Valuation (TTM | estimate)
P/E
15.3
P/S
1.4 | 1.4
EV/Sales
1.7 | 1.7
EV/FCF
-
P/B
1.0
Dividends
DPS
HK$0.17
Yield 1Y | 5Y
3.5% | 3.4%
Growth 1Y | 5Y
-35.0% | 9.0%
Payout 1Y | 3Y
48.3% | 43.3%
Increased
0 Years
Financials (TTM | estimate)
Revenue
HK$12.6b | HK$12.9b
EBITDA
-
EBIT
HK$1.7b
Net Income
HK$1.1b
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
6.6% | 5.1%
EBITDA
-
EBIT
-13.8%
Net Income
-46.1%
Free Cash Flow
-
Margin
Gross
52.1%
EBITDA
-
EBIT
13.8%
Net
9.0%
Free Cash Flow
-
Financial Health
Equity Ratio
62.6%
Return on Equity
7.3%
ROCE
7.9%
ROIC
6.3%
Debt/Equity
0.3
More
EPS
HK$0.3
FCF per Share
-
Short interest
-
Employees
13k
Rev per Employee
HK$970.0k

Grand Pharmaceutical Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Grand Pharmaceutical forecast:

5x Buy
83%
1x Hold
17%

Analyst Opinions

6 Analysts have issued a Grand Pharmaceutical forecast:

Buy
83%
Hold
17%

Financial data from Grand Pharmaceutical

Jun '26
+/-
%
12,565 12,565
7% 7%
100%
- Direct Costs 6,017 6,017
21% 21%
48%
6,548 6,548
4% 4%
52%
- Selling and Administrative Expenses 4,877 4,877
4% 4%
39%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 1,736 1,736
14% 14%
14%
Net Profit 1,133 1,133
46% 46%
9%

In millions HKD.

Don't miss a Thing! We will send you all news about Grand Pharmaceutical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Grand Pharmaceutical Group Ltd. is an investment holding company, which engages in the development, manufacture and distribution of pharmaceutical products. The company employs 11,987 full-time employees The firm is mainly engaged in the manufacture and sale of pharmaceutical preparations and medical devices. The firm is also engaged in the manufacture and sale of biotechnology products, health products, specialised pharmaceutical raw materials and other products. The firm's main products include nuclear medicine anti-tumor diagnosis and treatment and cardiovascular and cerebrovascular interventional diagnosis and treatment technology products.

Head office Hong Kong
Employees 12,614
Website www.grandpharma.cn

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today